Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Editor's comment

Patrick C Walsh

    BJU International
    |June 8, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation.

    The Prostate·2026
    Same author

    Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes.

    The Prostate·2025
    Same author

    Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN Guidelines.

    The Prostate·2025
    Same author

    Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate Cancer.

    European urology focus·2025
    Same author

    Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry.

    The Prostate·2022
    Same author

    A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.

    European urology·2022
    Same journal

    Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

    BJU international·2026
    Same journal

    Outcomes of maintenance BCG versus gemcitabine/docetaxel following BCG induction in NMIBC.

    BJU international·2026
    Same journal

    A call for regimen agnostic circulating tumour DNA-guided adjuvant selection in muscle-invasive bladder cancer.

    BJU international·2026
    Same journal

    Ablative radiotherapy in castration-resistant prostate cancer.

    BJU international·2026
    Same journal

    Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer.

    BJU international·2026
    Same journal

    Venous thromboembolism after penile cancer surgery: a UK PeCaN study.

    BJU international·2026
    See all related articles